Fabrizio Freda
President, and Chief Executive Officer at Estée Lauder Companies
Thank you, Rainey, and hello to everyone. We appreciate you being with us today to discuss our third quarter results and revised outlook for fiscal year 2023.
In the third quarter, organic sales fell 8% at the high-end of our outlook range, and the sequential improvements from the decline of 11% in the second quarter. Nearly all developed and emerging markets grew organically, and outperformed our expectations to offset an even lower-than-expected recovery in our Asia travel retail business.
As we discussed in February, Asia travel retail faced two headwinds in the third quarter. The first, elevated inventory in Hainan, given retailers 'expectation for a more accelerated recovery proved very challenging, as conversion of travelers to consumers in prestige beauty lagged historical trends, as travels initially gravitated through other categories. This led to even lower replenishment orders than we anticipated.
The second headwind, the transition in Korea to post-pandemic regulations as traveling consumers gradually returned pressured sales meaningfully. In China and Korea, the resumption of international flight was subdued. Limited visas were granted, and group tours were slow to restart. These factors resulted in lower-than-expected traffic in airports throughout the region, which combined with a lower-than-expected conversion further moderated replenishment orders.
With this said, there were bright spots for travel retail in Hong Kong, Macau, Europe, and the Americas. All told, global travel retail organic sales declined 45%. This was partially offset by excellent organic sales growth of 10% in the rest of our global business. Our retail sales growth was even stronger than organic sales growth in many markets around the world, including China and the US. Encouragingly, retail sales performance is significantly ahead of organic sales result in global travel retail, which gives us confidence that the challenges in travel retail are abating with time.
Furthermore, this strength at retail, including prestige beauty share gains in many markets demonstrated a benefit of our continuing investment in innovation and building the desirability of our brand around the world. These positive retail trends are expected to continue in the fourth quarter.
Adjusted diluted EPS in the fiscal third quarter fell 75%, which was also at the high-end of our outlook. We invested to fuel market in various stages of post-pandemic recovery, launching sought-after innovation, expanding brand into markets, and increasing advertising as percentage of sales. As the shape recovery for Asia travel retail comes into a better focus, it is proving to be both far more volatile than we expected, and more gradual relative to what we experienced in other markets. We are, therefore, lowering our organic sales and EPS outlook for fiscal year 2023, as we reduced our implied fourth quarter outlook, primarily for Asia travel retail.
For Asia travel retail, there are two factors driving our revised outlook. In Hainan, the pressure from elevated inventory in the trade is proving to be deeper and longer-lasting driven by this lower-than-expected consumption trend I discussed compounded by the retailer inventory tightening. Second, the resumption of international travel by Chinese consumer is evolving more slowly than we anticipated.
Having visited Shanghai and Hainan in March, and witnessed firsthand the optimism of consumers, retailers, partners, and our local teams, I am very encouraged for the future of our business with the Chinese consumers. I also had the good fortune to officially open our new China Innovation Lab and met with the amazing scientist and product development specialist in the state-of-art R&D facility which further bolstered my confidence in the business fundamentals. Indeed, the opportunity for prestige beauty and our brands with the Chinese consumer in the medium-to-long term remains vibrant in the domestic market, in Hainan, and internationally, which remains our focus through this complex phase of recovery from the pandemic.
For our fourth quarter outlook, the far slower organic sales growth that we anticipated in February is impacting profitability significantly. There are two factors at play be under pressure to a bigger margin accretive area of our business. First, with the rest of the business growing strongly, we will continue to invest to drive the momentum in those areas.
Second, strategic and necessary long-term investments in manufacturing, R&D, and information technology capabilities are pressuring margin with the slow recovery of sales. With this said, we are obviously not satisfied by the profitability in our revised outlook for fiscal year 2023. For the future, we are focused on a plan to further accelerate our growth in key markets, return to organic sales growth in our Asia travel retail business, and skincare category, and to progressively rebuild margin across brands, categories, and regions.
Let me now share more about our third quarter performance as numerous growth engines excelled. Looking at regions, each of the Americas and Asia-Pacific returned to organic sales growth, which complemented ongoing gains in the domestic markets of EMEA. Developed markets from every region contributed, led by the United States, the UK, and Hong Kong. While organic sales in our emerging markets grows an outstanding 17% globally. Impressively, in the domestic markets of EMEA, we realized broad-based trends as every category grew double-digits organically. The breadth of growth engines by category was matched by the breadth of growth engines by channel, led by specialty-multi and online [Indecipherable], driven by the successful go-to-market strategy as we focus on high-potential channels.
In Western Europe, our brands successfully engaged with consumers to generate trial and repeat. The examples are many Estee Lauder, Bobbi Brown, and Too Faced driving vital success on TikTok to M.A.C, leveraging Paris Fashion Week for its M.A.C Locked Kiss Ink lipstick launch, and La Mer hosting dermatologists for a unique event. This collective initiatives featuring enticing innovation in hero brands drove the company accelerating prestige beauty share gains for the quarter in Western Europe.
Looking at Asia-Pacific, it similarly delivered diversified growth in nearly every market, and each category contributed to the region's return to organic sales growth. Fragrance was a standout rising double-digit fueled by excellent performance of our luxury and our seasonal portfolio led by Jo Malone London, Le Labo, and TOM FORD Beauty. These brands hero franchises welcome new consumers into the category, while locally inspire innovation and enriching in-store services further contributed to the expansion of this promising category in the region.
Mainland China grew low single-digits organically, after four quarters of pressure from COVID-19 restrictions and outbreaks. The beginning of the quarter was impacted by the lingering effect of the COVID cases in November, December. In January, retailers were to existing inventory as traffic gradually returned, such that organic sales declined steep double-digits. As the reopening progressed, organic sales rose double-digit in each of February and March.
Even in this complex quarter in Mainland China, consumer desire for high-quality products elevated experience as newness was clear, and our brands delivered led by Estee Lauder and La Mer. For Estee Lauder, skincare fueled its growth. Consumer gravitated to the brands innovation, and cheered across franchises, most especially its luxury-oriented ReNutriv, as well as Supreme. La Mer further contributed, boosted by its beauty advisor offering, differentiated services, and the launch of reformulated moisturizing soft cream, which attracted new consumer with its advanced benefits. Encouragingly for the third quarter, our prestige beauty share gains in Mainland China accelerated sequentially, driven by skincare as well as both online and brick-and-mortar.
In the Americas, the United States returned to organic sales growth, invigorated by strategic go-to-market initiatives and innovation to engage existing as well as new consumers. The Ordinary asset originally growing to a hero and winning streak of innovation with the latest being multi-peptide eye serum, which is bringing in the new consumer demographic. Estee Lauder introduction of the revamped nutritious franchise focused on Jed Zed [Phonetic] with all new skincare products and launched exclusively with Ulta Beauty realized strong initial uptake.
Looking at makeup in the United States, M.A.C, Clinique, and Too Faced fueled excellent performance with targeting initiative to serve various consumer demographic across freestanding stores, specialty-multi, and department stores.
For Clinique, it is a case study in successfully leveraging vital success of a product. In it's case, Almost Lipstick and Black Honey to drive organic sales growth in many sub-categories. Across regions, emerging market showed their promise as a long-term growth engine. As our in-market team executed with excellence to meet the local needs of consumers. The double-digit organic sales growth in emerging market this quarter extends our fiscal year-to-date momentum with strong contribution from India and Brazil.
Globally, our diverse portfolio brands served as a powerful catalyst for growth. M.A.C, Tom Ford Beauty, The Ordinary, and Le Labo each contributed strong organic sales growth and demonstrated again to be ahead across our large-scale and developing brands. M.A.C with its global reach, [Indecipherable] service-oriented freestanding stores continue to realize the evolution of the make-up renaissance as markets progressed in recovery from the pandemic.
Furthermore, the brand leverage is market-leading EMV ranking with high inactivation and product launches in makeup. Consumers also embraced M.A.C new Hyper Real franchise in skincare, which should represent an incremental growth engine for the brand over time. Importantly, Hyper Real is another example in our portfolio of exciting east-to-west innovation as it was born in Asia-Pacific and launched globally.
Tom Ford Beauty delivered double-digit organic sales growth excelling across fragrance and make-up. In fragrance, The new Private Blend Cherry Collection was an instant hit while the brand's extension of Tom Ford Noir Extreme Eau De Parfum into the parfum category the consumer seeking intensity and the highest quality. We are thrilled to having reached our brand portfolio last week when we acquired Tom Ford, a power player in luxury with promising growth opportunities ahead. The deal is a wonderful outcome of our successful journey with the brand, which began when we collaborated to create TOM FORD Beauty over 15 years ago.
The Ordinary ingredient-focused product prospered in its heritage as well as in new market evident by the brand's very successful February launch in the Middle East, while Le Labo continued to evolve from strength to strength globally, rising 60% organically.
In closing, while we are lowering our outlook for fiscal year 2023 to reflect the deeper pressure in Asia travel retail given its standard recovery and related retail inventory tightening, we are encouraged by the strong momentum in the rest of our business. Looking ahead, we are focused on a strong acceleration, balanced organic sales growth across regions, categories, and channels and progressively rebuilding margin.
Indeed, consumer demand is robust for our diverse portfolio brands in developed and emerging markets globally evidenced in both organic sales growth and retail sales trends. This drives our confidence in the future. To our employees, I extend my deepest gratitude for your exceptional dedication to our company and each other amid a difficult external environment. You have demonstrated an unwavering passion to exceed consumer desires around the world with our beautiful portfolio brands.
I will now turn the call over to Tracey.